RxDoctor Payments Data

Monica Lyons

Family · Grand Haven, MINPI 1205989704

Payments from drug & device makers

$1,338in general payments, 2019–2025

Across 82 payments — averaging $16.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$337
  • Pfizer$289
  • AbbVie$260
  • AstraZeneca$142
  • GSK$56
  • Alkermes, Inc.$33
  • plus $222 from 11 others

What the payments were for

  • Food & beverage$1,338100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,338 in reported general payments places this provider in the 75th percentile of 3,657 family providers in Michigan.

See all family providers in Michigan

Medicare billing

Part B allowed, 2024
$14,269
Medicare patients
67
Services billed
166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban41$46,906
JardianceEmpagliflozin31$40,576
OzempicSemaglutide27$27,506
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$23,833
TrulicityDulaglutide24$23,068
VraylarCariprazine Hcl12$20,116
Atorvastatin Calcium295$5,517
Levothyroxine Sodium225$4,070
Fluticasone-SalmeterolFluticasone Propion/Salmeterol15$3,341
Humalog Kwikpen U-100Insulin Lispro11$3,290
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$2,934
Estradiol36$2,907
Losartan Potassium157$2,866
Omeprazole128$2,786
Desvenlafaxine Succinate ErDesvenlafaxine Succinate31$2,624

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$289$46,90641 claims
Boehringer IngelheimJardiance$19$40,57631 claims
Novo NordiskOzempic$337$27,50627 claims
GSKTrelegy Ellipta$56$23,83332 claims
Lilly USA, LLCTrulicity$32$23,06824 claims
AbbVieVraylar$260$20,11612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,657 family providers in Michigan.

Other family in Grand Haven

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →